05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
In light of the decision rendered by the California State Senate misclassifying self-employed worker...
Read More >
Private equity sponsors recently won a significant court victory that may result in increased appeti...
Read More >
A hot-button issue in California is whether an employer is required to pay for or reimburse an emplo...
Read More >
Much has already been written regarding the potential of COVID-19 to impact construction or developm...
Read More >
A round-up of the key legislation, guidance and measures issued to help the UK construction industry...
Read More >
After watching The Irishman on Netflix, I’m left with two overriding thoughts: One, my God, that’s...
Read More >